Search research articles
Contact Us
Filters
Showing results (31-40 of 95) with videos related to
Page
of 10
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
June 3, 2009
Lower doses of rFVIIa therapy are safe and effective for surgical interventions in patients with severe FXI deficiency and inhibitors
G Kenet, A Lubetsky, J Luboshitz, et al.
Alimentary Pharmacology & Therapeutics
|
October 20, 2007
Clinical trial: evaluation of a clinical decision-support model for upper abdominal complaints in primary-care practice
N Horowitz, M Moshkowitz, M Leshno, et al.
The Journal of Trauma
|
September 6, 2001
Recombinant activated factor VII for adjunctive hemorrhage control in trauma
U Martinowitz, G Kenet, E Segal, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
August 30, 2002
Efficacy and safety of a factor VIII-von Willebrand factor concentrate 8Y: stability, bacteriological safety, pharmacokinetic analysis and clinical experience
A Lubetsky, U Martinowitz, J Luboshitz, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
May 7, 2011
Thrombocytopenia and bleeding in dental procedures of patients with Gaucher disease
N Givol, G Goldstein, O Peleg, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
July 21, 2011
On-demand treatment of bleeds in haemophilia patients with inhibitors: strategies for securing and maintaining predictable efficacy with recombinant activated factor VII
B Sørensen, Y Dargaud, G Kenet, et al.
Gastroenterology
|
October 1, 1992
Bromobenzene accelerates hepatocyte streaming in rats
N Arber, G Zajicek, R Shamir, et al.
Alimentary Pharmacology & Therapeutics
|
April 1, 1997
Anti-thyroid drugs decrease mucosal damage in a rat model of experimental colitis
R Oren, Y Maaravi, F Karmeli, et al.
Thrombosis and Haemostasis
|
March 4, 1999
Safety and efficacy of continuous infusion of a combined factor VIII-von Willebrand factor (vWF) concentrate (Haemate-P) in patients with von Willebrand disease
A Lubetsky, S Schulman, D Varon, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
June 23, 2017
Estimating the potential cost of a high dose immune tolerance induction (ITI) therapy relative to the cost of a combined therapy of a low dose ITI therapy with bypassing agent prophylaxis
G Kenet, A Oladapo, J D Epstein, et al.
Page
of 10
Search research articles
Search
Showing results (31-40 of 95) with videos related to
Sort By:
Page
of 10
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
June 3, 2009
Lower doses of rFVIIa therapy are safe and effective for surgical interventions in patients with severe FXI deficiency and inhibitors
G Kenet, A Lubetsky, J Luboshitz, et al.
Alimentary Pharmacology & Therapeutics
|
October 20, 2007
Clinical trial: evaluation of a clinical decision-support model for upper abdominal complaints in primary-care practice
N Horowitz, M Moshkowitz, M Leshno, et al.
The Journal of Trauma
|
September 6, 2001
Recombinant activated factor VII for adjunctive hemorrhage control in trauma
U Martinowitz, G Kenet, E Segal, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
August 30, 2002
Efficacy and safety of a factor VIII-von Willebrand factor concentrate 8Y: stability, bacteriological safety, pharmacokinetic analysis and clinical experience
A Lubetsky, U Martinowitz, J Luboshitz, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
May 7, 2011
Thrombocytopenia and bleeding in dental procedures of patients with Gaucher disease
N Givol, G Goldstein, O Peleg, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
July 21, 2011
On-demand treatment of bleeds in haemophilia patients with inhibitors: strategies for securing and maintaining predictable efficacy with recombinant activated factor VII
B Sørensen, Y Dargaud, G Kenet, et al.
Gastroenterology
|
October 1, 1992
Bromobenzene accelerates hepatocyte streaming in rats
N Arber, G Zajicek, R Shamir, et al.
Alimentary Pharmacology & Therapeutics
|
April 1, 1997
Anti-thyroid drugs decrease mucosal damage in a rat model of experimental colitis
R Oren, Y Maaravi, F Karmeli, et al.
Thrombosis and Haemostasis
|
March 4, 1999
Safety and efficacy of continuous infusion of a combined factor VIII-von Willebrand factor (vWF) concentrate (Haemate-P) in patients with von Willebrand disease
A Lubetsky, S Schulman, D Varon, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
June 23, 2017
Estimating the potential cost of a high dose immune tolerance induction (ITI) therapy relative to the cost of a combined therapy of a low dose ITI therapy with bypassing agent prophylaxis
G Kenet, A Oladapo, J D Epstein, et al.
Page
of 10